About Proclin
At Proclin Research, it's personal.
We deliver a level of collaboration and control not possible in a traditional CRO environment — guiding sponsors successfully throughout their clinical development programs.
Who We Are
A patient-first CRO built on trust, flexibility and consistency.
Since incorporation, Proclin Research has initiated studies across Oncology, Endocrinology, Cardiology and Ophthalmology — and our management has successfully coordinated and completed over 150 clinical trials across a variety of therapeutic areas.
Our core values form the basis of our insight-driven strategic decision-making. This ensures a pipeline of the best possible medical therapeutics and devices for patients — reaching them efficiently and without delay.
What makes us different? Experience, flexibility and consistency. We aim for complete accountability and transparency across every partnership.
Our Values
The principles we live by
Patient First
Every decision begins with the patient. Ethical, patient-centric conduct is the foundation of every trial we run.
Committed to Ethical Conduct
Integrity is non-negotiable. We uphold ICH-GCP, 21 CFR Part 11 and international confidentiality laws without compromise.
Access to New Medicine
We accelerate the path from protocol to patient, guiding sponsors successfully through clinical development.
Better Public Health
Our work exists to improve outcomes at scale — bringing quality research closer to the communities who need it.
Clinical Trials Completed
Continents — India & Europe
Therapeutic Areas
Compliance Commitment